StockDuty Jun 23, 2026 04:00 PM ET
CatalystEarnings

$BEKE — BUY 📊 | 6 MONTHS THESIS

BEKE
$14.26
-0.28%
$BEKE — BUY 📊 | 6 MONTHS THESIS 🎯 latest | Rev $14.3B | EPS $1.42 vs $0.91 🟢 💡 Consensus sees China property as a bottomless pit, estimating flat or declining earnings, while BEKE's operational leverage and share gains drive high-teens EPS growth; the market is wrong because it underestimates a secular shift toward existing home transactions and BEKE's fixed-cost absorption. 📉 Reward/risk: 2.2:1 🏢 Business Quality: 7/10 - dominant platform with network effects, data advantage, and recurring revenue, but cyclical and policy-sensitive. 📊 Valuation: cheap — 12x forward non-GAAP P/E (vs 5-year median 25x), 6x EV/EBITDA, >10% adjusted FCF yield; DCF at 10% WACC implies $24, sum-of-parts $25+;... 🔮 Catalyst: Q1 2024 earnings (May) or government easing of home purchase restrictions 💰 Entry: $14.85, stop $12.5, target $20.0 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/BEKE0623
🎯 latest | Rev $14.3B | EPS $1.42 vs $0.91 🟢
Sources
pipeline